Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Alison M Weppler; Andrew Pattison; Prachi Bhave; Paolo De Ieso; Jeanette Raleigh; Athena Hatzimihalis; Anthony J Gill; Shiva Balachander; Jason Callahan; Margaret Chua; George Au-Yeung; Grant A McArthur; Rodney J Hicks; Richard W Tothill; Shahneen Sandhu

doi:10.1136/jitc-2020-000700

Article info

PDF

PDF +
Supplementary
Material

XML

Immunotherapy biomarkers

Original research

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Authors

Alison M Weppler Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Andrew Pattison Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Prachi Bhave Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Paolo De Ieso Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Jeanette Raleigh Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Athena Hatzimihalis Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Anthony J Gill Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney, New South Wales, Australia Department of Anatomical Pathology, University of Sydney, Sydney, New South Wales, Australia PubMed articles Google scholar articles
Shiva Balachander Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Jason Callahan Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Margaret Chua Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
George Au-Yeung Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Grant A McArthur Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Rodney J Hicks Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Richard W Tothill Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia Department of Clinical Pathology and Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia PubMed articles Google scholar articles
Shahneen Sandhu Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia PubMed articles Google scholar articles

Citation

Weppler AM, Pattison A, Bhave P, et al

Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma

Journal for ImmunoTherapy of Cancer 2020;8:e000700. doi: 10.1136/jitc-2020-000700

Online issue publication

October 15, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password